Dottikon ES Holding AG Overview
Pro stress-test →Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries in Europe, Switzerland, the United States, and Asia. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and positions itself as strategic development and manufacturing partner and performance leader.
Strategic Profile
Pro stress-test →The company's ownership alignment ensures that management remains focused on value creation rather than quarterly earnings, while its capital allocation discipline has consistently driven margin expansion. Dottikon's strategic focus on specialty chemicals positions it to benefit from several tailwinds including the global shift toward clean energy, electric vehicles, and advanced pharmaceuticals, with expertise in active pharmaceutical ingredients (APIs) and industrial coatings aligned with demand from biotech firms and EV manufacturers.
Competitive Landscape
Pro stress-test →Dottikon operates in the specialty chemicals sector forecasted to grow at 3.5% in 2025, with positioning in high-performance additives and solubility enhancers for clean energy, electric vehicles, and advanced pharmaceuticals. Primary competitors include major fine chemical manufacturers in pharmaceutical APIs and industrial coatings.
Industry Context
Dottikon ES Holding AG operates in Specialty Chemicals & Pharmaceutical Intermediates.
Key facts
Founded: 1913 · Headquarters: Dottikon, Switzerland · Employees: 841 · Revenue: CHF 392.68M (2024) · Market cap: CHF 4.34B